A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT-Reference-Cited by-同舟云学术

A Randomized, Controlled Study to Assess the Conversion From Calcineurin-Inhibitors to Everolimus After Liver Transplantation-PROTECT

Published:2012-04-11 Issue:7 Volume:12 Page:1855-1865
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Fischer L.,Klempnauer J.,Beckebaum S.,Metselaar H. J.,Neuhaus P.,Schemmer P.,Settmacher U.,Heyne N.,Clavien P-A.,Muehlbacher F.,Morard I.,Wolters H.,Vogel W.,Becker T.,Sterneck M.,Lehner F.,Klein C.,Kazemier G.,Pascher A.,Schmidt J.,Rauchfuss F.,Schnitzbauer A.,Nadalin S.,Hack M.,Ladenburger S.,Schlitt H. J.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2012.04049.x/fullpdf

Reference20 articles.

1. Chronic renal failure after transplantation of a nonrenal organ;Ojo;N Engl J Med,2003

2. Chronic renal dysfunction late after liver transplantation;Cohen;Liver Transpl,2002

3. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment;Gonwa;Transplantation,2001

4. Chronic renal dysfunction after liver transplantation in adult patients: Prevalence, risk factors, and impact on mortality;Moreno;Transplant Proc,2003

5. Independent risk factors and natural history of renal dysfunction in liver transplant recipients;Pawarode;Liver Transpl,2003

Cited by 171 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions;Expert Review of Clinical Pharmacology;2024-05-16

3. How to prevent chronic kidney disease after liver transplantation?;Annals of Liver Transplantation;2024-05-16

4. Immunosuppression in liver transplant oncology: position paper of the Italian Board of Experts in Liver Transplantation (I-BELT);Updates in Surgery;2024-05-07

5. Recurrent rejections after liver transplantation for hepatocellular carcinoma with stem cell features in an adult patient;Acta Clinica Belgica;2024-05-03